Comparative anti-inflammatory activity of poly(amidoamine) (PAMAM) dendrimer-dexamethasone conjugates with dexamethasone-liposomes

International Journal of Pharmaceutics

Volumn 449, Issue 1-2, 2013, Pages 28-36

  Choksi, Arpankumar ^a   Sarojini, K V L ^a   Vadnal, Prashant ^b   Dias, Charmaine ^b   Suresh, P K ^a   Khandare, Jayant ^b,c  

^a VIT UNIVERSITY   (India)

^b Piramal Enterprises Limited   (India)

^c MAEER S MAHARASHTRA INSTITUTE OF PHARMACY   (India)

Author keywords

Anti inflammatory; Dendrimer; Dexamethasone; Drug delivery; Nanodelivery; TNF inhibition

Indexed keywords

DENDRIMER; DEXAMETHASONE; LIPOSOME; NANOCARRIER; POLYAMIDOAMINE; PRODRUG; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONJUGATION; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; NANOENCAPSULATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; DENDRIMERS; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LIPOSOMES; PRODRUGS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84877031557     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.03.056     Document Type: Article

References (49)

1. Aher, N., Banerjee, S., Bhansali, S., Yadav, R., Shidore, M., Mhaske, S., Chaudhary, R., Asai, S., Jalota-Badhwar, A., Khandare, J., 2012. PEG versus dendrimer prodrug conjugates: influence of prodrug architecture in cellular uptake and transferring-mediated targeting (accepted 2012).
2. S.A. Asgeirsdóttir, J.A. Kamps, H.I. Bakker, P.J. Zwiers, P. Heeringa, K. van der Weide, H. van Goor, A.H. Petersen, H. Morselt, H.E. Moorlag, E. Steenbergen, C.G. Kallenberg, and G. Molema Site-specific inhibition of glomerulonephritis progression by targeted delivery of dexamethasone to glomerular endothelium Mol. Pharmacol. 72 2007 121 131
3. U. Bhardwaj, and D.J. Burgess Physicochemical properties of extruded and non-extruded liposomes containing the hydrophobic drug dexamethasone Int. J. Pharm. 388 2010 181 189
4. M.R. Bhonde, R.D. Gupte, S.D. Dadarkar, M.G. Jadhav, A.A. Tannu, P. Bhatt, D.R. Bhatia, N.K. Desai, V. Deore, N. Yewalkar, R.A. Vishwakarma, S. Sharma, S. Kumar, and N.M. Dagia A novel mTOR inhibitor is efficacious in a murine model of colitis Am. J. Physiol. Gastrointest. Liver Physiol. 295 2008 1237 1245
5. J.S. Choi, K.S. Ko, J.S. Park, Y.H. Kimd, S.W. Kime, and M. Lee Dexamethasone conjugated poly(amidoamine) dendrimer as a gene carrier for efficient nuclear translocation Int. J. Pharm. 320 2006 171 178
6. N.M. Dagia, G. Agarwal, D.V. Kamath, A. Chetrapal-Kunwar, R.D. Gupte, M.G. Jadhav, S.S. Dadarkar, J. Trivedi, A.A. Kulkarni-Almeida, F. Kharas, L.C. Fonseca, S. Kumar, and M.R. Bhonde A preferential p110α/γPI3K inhibitor attenuates experimental inflammation by suppressing the production of proinflammatory mediators in a NF-κB-dependent manner Am. J. Physiol. Cell Physiol. 298 2010 929 941
7. R. Duncan The dawning era of polymer therapeutics Nat. Rev. Drug Discov. 2 2003 347 360
8. J.D. Eichman, A.U. Bielinska, J.F. Kukowska-Latallo, and J.R. Baker Jr. The use of PAMAM dendrimers in the efficient transfer of genetic material into cells Pharm. Sci. Technol. Today 3 2000 232 245
9. R. Esfand, and D.A. Tomalia Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications Drug Discov. Today 6 2001 427 436
10. S. Gurdag, J. Khandare, S. Stapels, L.H. Matherly, and R.M. Kannan Activity of dendrimer-methotrexate conjugates on methotrexate-sensitive and -resistant cell lines Bioconjug. Chem. 2 2006 275 283
11. E. Hitti, T. Iakovleva, M. Brook, S. Deppenmeier, A.D. Gruber, D. Radzioch, A.R. Clark, P.J. Blackshear, A. Kotlyarov, and M. Gaestel Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element Mol. Cell Biol. 26 2006 2399 2407
12. H.Y. Kamiya, F.I. Matsuoka, and H. Harashima Visualization of intracellular trafficking of exogenous DNA delivered by cationic liposomes Biochem. Biophys. Res. Commun. 298 2002 591 597
13. M.K. Kelly, B.K. Rohit, W.S. Peter, and H. Gandehari Endocytosis inhibitors prevent poly(amidoamine) dendrimer internalization and permeability across caco-2 cells Mol Pharm. 5 2008 364 369
14. J.J. Khandare, P. Kolhe, O. Pillai, S. Kannan, M. Lieh-Lai, and R.M. Kannan Synthesis cellular transport, and activity of polyamidoamine dendrimer-methylprednisolone conjugates Bioconjug. Chem. 16 2005 330 337
15. J.J. Khandare, S. Jayant, A. Singh, P. Chandna, Y. Wang, N. Vorsa, and T. Minko Dendrimer versus linear conjugate: influence of polymeric architecture on the delivery and anticancer effect of paclitaxel Bioconjug. Chem. 17 2006 1464 1472
16. J. Khandare, M. Calderón, N.D. Dagia, and R. Haag Multifunctional dendritic polymers in nanomedicine: opportunities and challenges Chem. Soc. Rev. 41 2012 2824 2848
17. H. Kobayashi, S. Kawamoto, S.K. Jo, H.L. Bryant, M.W. Brechbiel, and R.A. Star Macromolecular MRI contrast agents with small dendrimers. Pharmacokinetic differences between sizes and cores Bioconjug. Chem. 14 2003 388 394
18. D. Kontoyiannis, M. Pasparakis, T.T. Pizarro, F. Cominelli, and G. Kollias Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies Immunity 10 1999 387 398
19. A. Kotlyarov, A. Neininger, C. Schubert, R. Eckert, C. Birchmeier, H.D. Volk, and M. Gaestel MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis Nat. Cell Biol. 1 1999 94 97
20. J.F. Kukowska Latallo, A.U. Bielinska, J. Johnson, R. Spindler, D.A. Tomalia, and J.R. Baker Efficient transfer of genetic material into mammalian cells using Starburst Polyamidoamine dendrimers Proc. Natl. Acad. Sci. U.S.A. 93 1996 4897 4902
21. J.F. Kukowska-Latallo, K.A. Candido, Z.Y. Cao, S.S. Nigavekar, I.J. Majoros, T.P. Thomas, L.P. Balogh, M.K. Khan, and J.R. Baker Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer Cancer Res. 65 2005 5317 5324
22. W.G. Lesniak, M.S.T. Kariapper, B.M. Nair, W. Tan, A. Hutson, L.P. Balogh, and M.K. Khan Synthesis and characterization of PAMAM dendrimer based multifunctional nanodevices for targeting αvβ3 integrins Bioconjug. Chem. 18 2007 1148 1154
23. D. Luo, K. Haverstick, N. Belcheva, E. Han, and W.M. Saltzman Poly (ethylene glycol)-conjugated PAMAM dendrimer for biocompatible high-efficiency DNA delivery Macromolecules 35 2002 3456 3462
24. H. Maeda, T. Sawa, and T. Konno Mechanism of tumor-targeted delivery of macromolecular drugs including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS J. Control. Release 74 2001 47 61
25. S.H. Medina, and M.E.H. El-Sayed Dendrimers as carriers for delivery of chemotherapeutic agents Chem. Rev. 109 2009 3141 3157
26. S.M. Moghimi, A.C. Hunter, and J.C. Murray Nanomedicine: current status and future prospects FASEB J. 19 2005 311 330
27. R.S. Navath, A.R. Menjoge, B. Wang, R. Romero, S. Kannan, and R.M. Kannan Amino acid-functionalized dendrimers with heterobifunctional chemoselective peripheral groups for drug delivery applications Biomacromology 11 2010 1544 1563
28. J.M. Oliveira, R.A. Sousa, N. Kotobuki, M. Tadokoro, M. Hirose, J.F. Mano, R.L. Reis, and H. Ohgushi The osteogenic differentiation of rat bone marrow stromal cells cultured with dexamethasone-loaded carboxymethylchitosan/ poly(amidoamine) dendrimer nanoparticles Biomaterials 30 2009 804 813
29. J.M. Oliveira, N. Kotobuki, M. Tadokoro, M. Hirose, J.F. Mano, R.L. Reis, and H. Ohgushi Ex vivo culturing of stromal cells with dexamethasone-loaded carboxymethylchitosan/poly(amidoamine) dendrimer nanoparticles promotes ectopic bone formation Bone 46 2010 1424 1435
30. J. Panyam, and V. Labhasetwar Biodegradable nanoparticles for drug and gene delivery to cells and tissue Adv. Drug Deliv. Rev. 55 2003 329 347
31. J. Panyam, and V. Labhasetwar Biodegradable nanoparticles for drug and gene delivery to cells and tissue Adv. Drug Deliv. Rev. 64 2012 61 71
32. J. Panyam, W.Z. Zhou, S. Prabha, S.K. Sahoo, and Labhasetwar V Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery FASEB J. 16 2002 1217 1226
33. A.K. Patri, I.J. Majoros, and J.R. Baker Dendritic polymer macromolecular carriers for drug delivery Curr. Opin. Chem. Biol. 6 2002 466 471
34. A. Quintana, E. Raczka, L. Piehler, I. Lee, A. Myc, I. Majoros, A.K. Patri, T. Thomas, J. Mule, and J.R. Baker Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor Pharm. Res. 19 2002 1310 1316
35. L. Rajendran, H.J. Knölker, and K. Simons Subcellular targeting strategies for drug design and delivery Nat. Rev. Drug Discov. 9 2010 29 42
36. G. Sahay, D.Y. Alakhova, and A.V. Kabanov Endocytosis of nanomedicines J. Control. Release 145 2010 182 195
37. S.K. Sahoo, and V. Labhasetwar Nanotech approaches to drug delivery and imaging Drug Discov. Today 8 2003 1112 1120
38. S.K. Sahoo, S. Parveen, and J.J. Panda The present and future of nanotechnology in human health care Nanomedicine 3 2007 20 31
39. B. Schimmer, and K. Parker Adrenocorticotropic hormone; adrenocortical steroids and their synthetic anlogues; inhibitors of the synthesis and actions of adrenocortical hormones J. Hardman, L. Limbard, A. Gilman, Goodman & Gilman's Pharmacological Basis of Therapeutics 2001 McGraw-Hill
40. X.Y. Shi, W. Lesniak, M.T. Islam, M.C. Muniz, L.P. Balogh, and J.R. Baker Comprehensive characterization of surface-functionalized poly (amidoamine) dendrimers with acetamide hydroxyl, and carboxyl groups Colloids Surf. A 272 2006 139 150
41. T.P. Thomas, I.J. Majoros, A. Kotlyar, J.F. Kukowska-Latallo, A. Bielinska, A. Myc, and J.R. Baker Targeting and inhibition of cell growth by an engineered dendritic nanodevice J. Med. Chem. 48 2005 3729 3735
42. T.P. Thomas, R. Shukla, I.J. Majoros, A. Myc, and J.R. Baker Poly (amidoamine) dendrimer-based multifunctional nanoparticles Nanobiotechnology: Concepts, Methods and Perspectives 2007 Wiley-VCH
43. D.A. Tomalia, and J.M.J. Fréchet Discovery of dendrimers and dendritic polymers: a brief historical perspective J. Polymer Sci. A Polymer Chem. 40 2002 2719 2728
44. V.P. Torchilin Recent advances with liposomes as pharmaceutical carriers Drug Discov. 4 2005 145 160
45. J.K. Vasir, and V. Labhasetwar Biodegradable nanoparticles for cytosolic delivery of therapeutics Adv. Drug Deliv. Rev. 59 2007 718 728
46. H. Wang, N. Kubica, L.W. Ellisen, L.S. Jefferson, and S.R. Kimball Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1 J. Biol. Chem. 281 2006 39128 39134
47. K. Yang, L. Weng, Y. Cheng, H. Zhang, J. Zhang, Q. Wu, and T. Xu Host-guest chemistry of dendrimer-drug complexes. Fully acetylated dendrimers as biocompatible drug vehicles using dexamethasone 21-phosphate as a model drug J. Phys. Chem. B 115 2011 2185 2195
48. Y. Zhang, T.P. Thomas, A. Desai, H. Zong, P.R. Leroueil, I.J. Majoros, and J.R. Baker Targeted dendrimeric anticancer prodrug: a methotrexate-folic acid-poly(amidoamine) conjugate and a novel rapid, one pot synthetic approach Bioconjug. Chem. 21 2010 489 495
49. L. Wang, M. Li, and N. Zhang Folate-targeted docetaxel-lipid-based- nanosuspensions for active-targeted cancer therapy Int J Nanomedicine 7 2012 3281 3294